0000899243-18-028966.txt : 20181114
0000899243-18-028966.hdr.sgml : 20181114
20181114210021
ACCESSION NUMBER: 0000899243-18-028966
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181112
FILED AS OF DATE: 20181114
DATE AS OF CHANGE: 20181114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: North Michael Paul
CENTRAL INDEX KEY: 0001689925
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 181185800
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY, SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-12
0
0000896262
AMEDISYS INC
AMED
0001689925
North Michael Paul
3854 AMERICAN WAY, SUITE A
BATON ROUGE
LA
70816
0
1
0
0
Chief Information Officer
Common Stock
2018-11-12
4
M
0
2264
32.56
A
23767
D
Common Stock
2018-11-12
4
S
0
2264
119.30
D
21503
D
Common Stock
2018-11-13
4
M
0
100
32.56
A
21603
D
Common Stock
2018-11-13
4
S
0
100
118.06
D
21503
D
Common Stock
2018-11-14
4
M
0
3261
32.56
A
24764
D
Common Stock
2018-11-14
4
S
0
3261
116.36
D
21503
D
Common Stock
391
I
Through 401(k) Plan
Stock Option (right to buy)
32.56
2018-11-12
4
M
0
2264
0.00
D
2025-06-02
Common Stock
2264
9236
D
Stock Option (right to buy)
32.56
2018-11-13
4
M
0
100
0.00
D
2025-06-02
Common Stock
100
9136
D
Stock Option (right to buy)
32.56
2018-11-14
4
M
0
3261
0.00
D
2025-06-02
Common Stock
3261
5875
D
The total amount of shares beneficially owned includes 761 shares held in an employee stock purchase plan account.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.00 to $119.80 inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.28 to $116.39 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
The information in this report is based on a plan statement dated as of September 30, 2018.
On June 2, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The stock options are subject to time-based vesting conditions. 5,625 of the options vested on each of June 2, 2016, June 2, 2017 and June 2, 2018, and the remaining 5,625 options will vest on June 2, 2019, provided that the reporting person remains continuously employed by the Issuer on such date, subject to pro-rated vesting provisions as provided in the award agreement for the stock option.
/s/ Jennifer R. Guckert, pursuant to a power of attorney
2018-11-14